23 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2221179/inspiremd-s-nspr-ce-mark-recertification-to-boost-cguard-eps?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221179
Feb 05, 2024 - InspireMD's (NSPR) CE Mark Recertification under MDR is likely to help the company boost the CGuard EPS for carotid artery revascularization care along with advancing with new products.
zc:3116508238562428467
0
https://www.zacks.com/stock/news/2228918/celanese-ce-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228918
Feb 20, 2024 - While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-8851443417454176921
0
https://www.zacks.com/stock/news/2245584/celanese-ce-gets-iscc-certified-for-low-carbon-ccu-methanol?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2245584
Mar 25, 2024 - Celanese (CE) now offers low-carbon choices to customers across its Acetyl Chain and Engineered Materials products under the ECO-CC name.
zc:-6052292743126367870
0